This inventor holds 3 USPTO granted patents and 4 EPO patents. Top assignees: Tibotec Pharmaceuticals Ltd., Janssen R&d Ireland, Medivir Ab. Active years: 2010-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 67 
1 out of 45 
1 out of 120 
Years Active: 2010-2015
Title: The Innovative Contributions of Björn Olof Classon
Introduction
Björn Olof Classon is a notable inventor based in Huddinge, Sweden. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit the hepatitis C virus (HCV). With a total of three patents to his name, Classon has established himself as a key figure in the fight against viral infections.
Latest Patents
Classon's latest patents include innovative compounds designed to combat HCV. One of his notable inventions is a pyrimidine substituted macrocyclic HCV inhibitor, which includes a stereoisomer, an N-oxide, a pharmaceutically acceptable addition salt, or a pharmaceutically acceptable addition solvate. These compounds are recognized for their utility as HCV inhibitors and include processes for their preparation as well as pharmaceutical compositions that incorporate these compounds as active ingredients. Another significant patent involves macrocyclic inhibitors of the hepatitis C virus, which are designed to inhibit HCV replication and include various forms such as N-oxides, salts, or stereoisomers.
Career Highlights
Throughout his career, Björn Olof Classon has worked with prominent companies in the pharmaceutical industry. He has been associated with Tibotec Pharmaceuticals Ltd. and Medivir AB, where he has contributed to the development of groundbreaking therapies. His work has been instrumental in advancing the understanding and treatment of hepatitis C.
Collaborations
Classon has collaborated with several esteemed professionals in his field, including Pierre Jean-Marie Bernard Raboisson and Karl Magnus Nilsson. These collaborations have further enriched his research and development efforts, leading to innovative solutions in the pharmaceutical landscape.
Conclusion
Björn Olof Classon is a distinguished inventor whose work has significantly impacted the development of HCV inhibitors. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile